Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,970.00
+70.00 (0.71%)
Last updated: May 15, 2026, 10:59 AM KST

KRX:007570 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
23,6544,2953,4147,1749,288
Short-Term Investments
5,9738,49510,2765,41934,111
Trading Asset Securities
----231.78
Cash & Short-Term Investments
29,62712,79013,69012,59343,631
Cash Growth
131.64%-6.57%8.72%-71.14%4.85%
Accounts Receivable
44,97244,77747,65648,76252,803
Other Receivables
3,9403,9364,6804,7163,297
Receivables
48,91248,71352,33653,47956,101
Inventory
64,24359,87353,10848,38732,423
Prepaid Expenses
651.12158.02186.42303.23515.3
Other Current Assets
4,3293,6524,3393,6563,671
Total Current Assets
147,762125,187123,659118,418136,340
Property, Plant & Equipment
220,675216,421181,973178,244175,779
Long-Term Investments
40,67843,51038,57252,84745,029
Other Intangible Assets
1,7121,8881,8261,9352,078
Long-Term Deferred Charges
24,03923,45325,53029,48134,392
Other Long-Term Assets
22,46420,56821,04621,99125,643
Total Assets
457,331431,027392,607402,916419,261
Accounts Payable
20,70422,32226,30729,81323,717
Accrued Expenses
480.55513.8398.44310.58314.19
Short-Term Debt
96,21692,50565,78971,00092,500
Current Portion of Long-Term Debt
3,333--2,000-
Current Portion of Leases
189.5266.59522.11370.52159.24
Current Income Taxes Payable
236.41,2931,126958.543,542
Other Current Liabilities
50,01240,64945,12140,87547,687
Total Current Liabilities
171,172157,549139,263145,328167,920
Long-Term Debt
26,66714,7006,000-5,000
Long-Term Leases
388.51209.38339.24732.69843.73
Pension & Post-Retirement Benefits
7,0188,5807,3227,9098,136
Long-Term Deferred Tax Liabilities
8,2278,5659,23310,66210,464
Other Long-Term Liabilities
2,4501,8915050021.5
Total Liabilities
215,922191,494162,207165,132192,385
Common Stock
47,71447,71447,71447,71447,714
Additional Paid-In Capital
78,37078,37078,44178,41678,590
Retained Earnings
122,790118,75953,55958,75943,170
Treasury Stock
-12,269-11,269-11,921-10,075-7,437
Comprehensive Income & Other
-114.371,26457,95758,49660,587
Total Common Equity
236,490234,838225,751233,311222,624
Minority Interest
3,8053,5823,5363,3613,139
Shareholders' Equity
241,409239,533230,400237,785226,876
Total Liabilities & Equity
457,331431,027392,607402,916419,261
Total Debt
126,794107,68172,65074,10398,503
Net Cash (Debt)
-97,168-94,891-58,960-61,511-54,872
Net Cash Per Share
-5277.21-5148.09-3272.13-3393.60-3014.10
Filing Date Shares Outstanding
19.7918.0117.9718.0918.21
Total Common Shares Outstanding
19.7918.0117.9718.0918.21
Working Capital
-23,410-32,362-15,604-26,910-31,580
Book Value Per Share
11951.5613036.8712561.4212899.4512228.63
Tangible Book Value
234,778232,951223,925231,375220,547
Tangible Book Value Per Share
11865.0512932.0712459.7912792.4612114.49
Land
118,556120,507120,298120,308116,955
Buildings
39,55841,12642,78744,47445,995
Machinery
2,9944,0556,0609,3679,480
Construction In Progress
58,41549,58311,4352,3841,953
Source: S&P Global Market Intelligence. Standard template. Financial Sources.